Cargando…
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway
Disulfide bond-disrupting agents (DDAs) are a new chemical class of agents recently shown to have activity against breast tumors in animal models. Blockade of tumor growth is associated with downregulation of EGFR, HER2, and HER3 and reduced Akt phosphorylation, as well as the induction of endoplasm...
Autores principales: | Wang, Mengxiong, Law, Mary E., Davis, Bradley J., Yaaghubi, Elham, Ghilardi, Amanda F., Ferreira, Renan B., Chiang, Chi-Wu, Guryanova, Olga A., Kopinke, Daniel, Heldermon, Coy D., Castellano, Ronald K., Law, Brian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904486/ https://www.ncbi.nlm.nih.gov/pubmed/31839995 http://dx.doi.org/10.1038/s41420-019-0228-9 |
Ejemplares similares
-
Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022) -
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells
por: Ferreira, Renan B., et al.
Publicado: (2017) -
Novel agents that downregulate EGFR, HER2, and HER3 in parallel
por: Ferreira, Renan Barroso, et al.
Publicado: (2015) -
Disruption of reducing pathways is not essential for efficient disulfide bond formation in the cytoplasm of E. coli
por: Hatahet, Feras, et al.
Publicado: (2010) -
A Single Disulfide Bond Disruption in the β3 Integrin Subunit Promotes Thiol/Disulfide Exchange, a Molecular Dynamics Study
por: Levin, Lihie, et al.
Publicado: (2013)